NordicNeuroLab AS

Based in Norway, NordicNeuroLab AS provides advanced diagnostic solutions for functional magnetic resonance imaging (fMRI), enhancing surgical planning and patient experience through innovative technologies. Founded in 2001 and headquartered in Bergen, Norway, NordicNeuroLab AS specializes in fMRI diagnostics. It has engaged in a single funding round, and on July 22, 2025, Longship acquired a majority stake in the company to bolster its business development. NordicNeuroLab specializes in providing an integrated hardware and software solution for functional magnetic resonance imaging (fMRI).

Their core offerings include high-end visual stimulation systems designed for use with 1. 5T and 3T MRI acquisitions, enabling neurosurgeons to enhance surgical planning through tools such as virtual reality, 3D printing, and neuronavigation systems. The company aims to alleviate discomfort during MRI exams by allowing patients to watch movies while undergoing scans, thus improving the overall patient experience. Their products are designed for a wide array of end users, including researchers, psychologists, surgeons, and radiographers, and have been implemented in over 2000 installations across more than 70 countries globally.

NordicNeuroLab serves diverse geographical markets, focusing on regions with advanced medical research facilities and hospitals that conduct neuroimaging studies. NordicNeuroLab's revenue generation is primarily concentrated on the sale of its fMRI systems and associated software solutions, which are typically structured as B2B transactions. Clients include hospitals, research institutions, and clinical facilities that purchase these integrated solutions to enhance their neuroimaging capabilities. Transactions involve the direct sale of hardware and software packages, supported by ongoing service agreements that provide technical assistance and training to ensure effective usage.

The company emphasizes the importance of enabling users to maximize the utility of their products, which may include post-processing software for neuroimaging analysis. Though specific pricing details are not disclosed, the transactions typically encompass both initial equipment costs and subsequent support services, reinforcing the commitment to customer satisfaction and effective application of their technology in clinical settings. In July 2025, Longship acquired a majority stake in NordicNeuroLab AS, with financial terms not disclosed. This acquisition will enhance the company's business development efforts, allowing for the design and launch of new products while also targeting expansion into new geographic markets.

Specific new products and their release dates have yet to be detailed, but the company is focused on enhancing its market presence to better serve clients in advanced medical research facilities and hospitals.